Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

70.250
-1.650-2.29%
Volume:2.45M
Turnover:175.39M
Market Cap:39.59B
PE:46.52
High:74.800
Open:73.600
Low:70.100
Close:71.900
52wk High:124.000
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:2.21
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.510
ROE:109.10%
ROA:39.01%
PB:4.07
PE(LYR):46.52
PS:4.22

Loading ...

Remegen Spends Approximately 3.05 Million Yuan to Buy Back 28,000 Shares on August 3

Stock News
·
Aug 03

Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News
·
Jul 31

RemeGen repurchases 13,000 A-shares for RMB1.43 million, outstanding share count falls 0.0037%

Bulletin Express
·
Jul 30

Movement Alert|REMEGEN Intraday Decline 5.02%, Ophthalmic Drug RC28-E Registration Apparently Rejected by NMPA

Market Focus
·
Jul 30

Nomura Adjusts RemeGen's Price Target to HK$89.44 From HK$79.64, Keeps at Neutral

MT Newswires Live
·
Jul 27

Movement Alert|REMEGEN Falls 5.1% in Regular Trading, Lock-Up Expiry Selling Pressure Compounded by Biotech Sector Pullback

Market Focus
·
Jul 24

Movement Alert|RemeGen Rises 4.23% in Regular Trading, A-Share Buyback Plan Enters Implementation Phase as Innovative Drug Sector Strengthens

Market Focus
·
Jul 22

Innovative Drug Stocks Rebound Swiftly, Leading ETF Surges as Sector Gains Momentum with Positive Developments from Multiple Companies

Deep News
·
Jul 20

REMEGEN Shares Surge Over 8% on Proposed A-Share Buyback and Positive Outlook for Telitacicept

Stock News
·
Jul 20

RemeGen Proposes Share Buyback of Up to 50 Million Yuan

MT Newswires Live
·
Jul 20

HK Movers | Biomedical Stocks Rally; REMEGEN, WUXI XDC and KEYMED BIO-B Surge Over 8%

Tiger Newspress
·
Jul 20

Hong Kong Stock Connect Biotech Sector Stages Strong Rebound, Key ETF Surges Over 4%; REMEGEN Announces Buyback, Leading Gains

Deep News
·
Jul 20

Hong Kong Stocks Add 2.0% in Morning Trading

Dow Jones
·
Jul 20

Movement Alert|RemeGen Rises 5.11% in Regular Trading, First A-Share Buyback Plan Boosts Market Confidence

Market Focus
·
Jul 20

Remegen Announces Share Buyback Plan Valued Between 25 Million and 50 Million Yuan

Stock News
·
Jul 19

Movement Alert|RemeGen Falls 5.06% in Regular Trading, Biotech Sector Broadly Weakens Amid Continued Lock-up Expiry Pressure

Market Focus
·
Jul 17

Movement Alert|RemeGen Rises 5.39% in Regular Trading, Telitacicept Inclusion in National Essential Drug List Continues to Drive Shares

Market Focus
·
Jul 15

REMEGEN Shares Surge Over 6% on Inclusion of Telitacicept in National Essential Drug List

Stock News
·
Jul 10

Biotech Stocks Surge as New National Essential Drug List Includes Innovative Therapies

Stock News
·
Jul 10

Movement Alert|RemeGen Rises 5.49% in Regular Trading, Core Product Telitacicept Included in New National Essential Drug List

Market Focus
·
Jul 10